Cargando…

Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany

BACKGROUND: Diffuse parenchymal lung diseases (DPLD) in children represent a rare and heterogeneous group of chronic pulmonary disorders. Despite substantial advances in genetics and pathomechanisms, these often lethal diseases are still under-diagnosed. This is due to the fact that (i) the incidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Griese, Matthias, Haug, Melanie, Brasch, Frank, Freihorst, Achim, Lohse, Peter, von Kries, Rüdiger, Zimmermann, Theodor, Hartl, Dominik
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800105/
https://www.ncbi.nlm.nih.gov/pubmed/20003372
http://dx.doi.org/10.1186/1750-1172-4-26
_version_ 1782175838120181760
author Griese, Matthias
Haug, Melanie
Brasch, Frank
Freihorst, Achim
Lohse, Peter
von Kries, Rüdiger
Zimmermann, Theodor
Hartl, Dominik
author_facet Griese, Matthias
Haug, Melanie
Brasch, Frank
Freihorst, Achim
Lohse, Peter
von Kries, Rüdiger
Zimmermann, Theodor
Hartl, Dominik
author_sort Griese, Matthias
collection PubMed
description BACKGROUND: Diffuse parenchymal lung diseases (DPLD) in children represent a rare and heterogeneous group of chronic pulmonary disorders. Despite substantial advances in genetics and pathomechanisms, these often lethal diseases are still under-diagnosed. This is due to the fact that (i) the incidence is low, and (ii) clinical presentation, (iii) disease classification and (iv) specific treatment options are largely unknown. METHODS: Here we systematically assessed the incidence, the presentation, the diagnostic yield and treatments of pediatric DPLD in Germany, using the Surveillance Unit for Rare Paediatric Disorders (ESPED). RESULTS: The incidence of DPLD was 1.32 new cases per 1 million of children per year. The majority of these children were diagnosed within the first year of life. Overall survival was 87%. Using centralized data entry and stratification tools, the patients were categorized into an advanced classification system based on diagnostic algorithms, including clinical presentations, genetics and/or histology. Combining molecular and clinical information, this survey provides an etiological overview and specific diagnostic recommendations for children with DPLD. CONCLUSIONS: Standardized surveys and systematic classifications are valuable tools for the clinical handling of children with DPLD and aim to improve the disease understanding and the prognosis of these rare detrimental lung diseases.
format Text
id pubmed-2800105
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28001052009-12-31 Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany Griese, Matthias Haug, Melanie Brasch, Frank Freihorst, Achim Lohse, Peter von Kries, Rüdiger Zimmermann, Theodor Hartl, Dominik Orphanet J Rare Dis Research BACKGROUND: Diffuse parenchymal lung diseases (DPLD) in children represent a rare and heterogeneous group of chronic pulmonary disorders. Despite substantial advances in genetics and pathomechanisms, these often lethal diseases are still under-diagnosed. This is due to the fact that (i) the incidence is low, and (ii) clinical presentation, (iii) disease classification and (iv) specific treatment options are largely unknown. METHODS: Here we systematically assessed the incidence, the presentation, the diagnostic yield and treatments of pediatric DPLD in Germany, using the Surveillance Unit for Rare Paediatric Disorders (ESPED). RESULTS: The incidence of DPLD was 1.32 new cases per 1 million of children per year. The majority of these children were diagnosed within the first year of life. Overall survival was 87%. Using centralized data entry and stratification tools, the patients were categorized into an advanced classification system based on diagnostic algorithms, including clinical presentations, genetics and/or histology. Combining molecular and clinical information, this survey provides an etiological overview and specific diagnostic recommendations for children with DPLD. CONCLUSIONS: Standardized surveys and systematic classifications are valuable tools for the clinical handling of children with DPLD and aim to improve the disease understanding and the prognosis of these rare detrimental lung diseases. BioMed Central 2009-12-12 /pmc/articles/PMC2800105/ /pubmed/20003372 http://dx.doi.org/10.1186/1750-1172-4-26 Text en Copyright ©2009 Griese et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Griese, Matthias
Haug, Melanie
Brasch, Frank
Freihorst, Achim
Lohse, Peter
von Kries, Rüdiger
Zimmermann, Theodor
Hartl, Dominik
Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany
title Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany
title_full Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany
title_fullStr Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany
title_full_unstemmed Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany
title_short Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany
title_sort incidence and classification of pediatric diffuse parenchymal lung diseases in germany
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800105/
https://www.ncbi.nlm.nih.gov/pubmed/20003372
http://dx.doi.org/10.1186/1750-1172-4-26
work_keys_str_mv AT griesematthias incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany
AT haugmelanie incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany
AT braschfrank incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany
AT freihorstachim incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany
AT lohsepeter incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany
AT vonkriesrudiger incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany
AT zimmermanntheodor incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany
AT hartldominik incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany